As per our findings, the Saudi Arabia market revenue stood at USD 1.87 billion in 2025.
Market projections show the Saudi Arabia Infusion Services Market is forecast to reach USD 6.12 billion by 2033, achieving a CAGR of 15.9% during the projection horizon.
Vision 2030 healthcare transformation continues to expand oncology centers and specialty hospital networks, strengthening infusion service density in Riyadh and Jeddah.
The Saudi Ministry of Health cancer statistics show rising treated case volumes, supporting long-term biologic infusion growth across public hospitals.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]